IBDEI2C2 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39562,1,3,0)
 ;;=3^Inflammation of Postprocedural Bleb,Stage 2
 ;;^UTILITY(U,$J,358.3,39562,1,4,0)
 ;;=4^H59.42
 ;;^UTILITY(U,$J,358.3,39562,2)
 ;;=^5006427
 ;;^UTILITY(U,$J,358.3,39563,0)
 ;;=H59.43^^153^1926^46
 ;;^UTILITY(U,$J,358.3,39563,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39563,1,3,0)
 ;;=3^Inflammation of Postprocedural Bleb,Stage 3
 ;;^UTILITY(U,$J,358.3,39563,1,4,0)
 ;;=4^H59.43
 ;;^UTILITY(U,$J,358.3,39563,2)
 ;;=^5006428
 ;;^UTILITY(U,$J,358.3,39564,0)
 ;;=H59.40^^153^1926^47
 ;;^UTILITY(U,$J,358.3,39564,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39564,1,3,0)
 ;;=3^Inflammation of Postprocedural Bleb,Unspec
 ;;^UTILITY(U,$J,358.3,39564,1,4,0)
 ;;=4^H59.40
 ;;^UTILITY(U,$J,358.3,39564,2)
 ;;=^5006425
 ;;^UTILITY(U,$J,358.3,39565,0)
 ;;=H54.8^^153^1926^48
 ;;^UTILITY(U,$J,358.3,39565,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39565,1,3,0)
 ;;=3^Legal Blindness,as Defined in USA
 ;;^UTILITY(U,$J,358.3,39565,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,39565,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,39566,0)
 ;;=H40.1231^^153^1926^35
 ;;^UTILITY(U,$J,358.3,39566,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39566,1,3,0)
 ;;=3^Glaucoma,Low-Tension,Mild Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,39566,1,4,0)
 ;;=4^H40.1231
 ;;^UTILITY(U,$J,358.3,39566,2)
 ;;=^5005768
 ;;^UTILITY(U,$J,358.3,39567,0)
 ;;=H40.1232^^153^1926^36
 ;;^UTILITY(U,$J,358.3,39567,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39567,1,3,0)
 ;;=3^Glaucoma,Low-Tension,Moderate Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,39567,1,4,0)
 ;;=4^H40.1232
 ;;^UTILITY(U,$J,358.3,39567,2)
 ;;=^5005769
 ;;^UTILITY(U,$J,358.3,39568,0)
 ;;=H40.1233^^153^1926^37
 ;;^UTILITY(U,$J,358.3,39568,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39568,1,3,0)
 ;;=3^Glaucoma,Low-Tension,Severe Stage,Bilateral
 ;;^UTILITY(U,$J,358.3,39568,1,4,0)
 ;;=4^H40.1233
 ;;^UTILITY(U,$J,358.3,39568,2)
 ;;=^5005770
 ;;^UTILITY(U,$J,358.3,39569,0)
 ;;=H52.13^^153^1926^49
 ;;^UTILITY(U,$J,358.3,39569,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39569,1,3,0)
 ;;=3^Myopia,Bilateral
 ;;^UTILITY(U,$J,358.3,39569,1,4,0)
 ;;=4^H52.13
 ;;^UTILITY(U,$J,358.3,39569,2)
 ;;=^5006266
 ;;^UTILITY(U,$J,358.3,39570,0)
 ;;=H52.12^^153^1926^50
 ;;^UTILITY(U,$J,358.3,39570,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39570,1,3,0)
 ;;=3^Myopia,Left Eye
 ;;^UTILITY(U,$J,358.3,39570,1,4,0)
 ;;=4^H52.12
 ;;^UTILITY(U,$J,358.3,39570,2)
 ;;=^5006265
 ;;^UTILITY(U,$J,358.3,39571,0)
 ;;=H52.11^^153^1926^51
 ;;^UTILITY(U,$J,358.3,39571,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39571,1,3,0)
 ;;=3^Myopia,Right Eye
 ;;^UTILITY(U,$J,358.3,39571,1,4,0)
 ;;=4^H52.11
 ;;^UTILITY(U,$J,358.3,39571,2)
 ;;=^5006264
 ;;^UTILITY(U,$J,358.3,39572,0)
 ;;=H40.053^^153^1926^52
 ;;^UTILITY(U,$J,358.3,39572,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39572,1,3,0)
 ;;=3^Ocular HTN,Bilateral
 ;;^UTILITY(U,$J,358.3,39572,1,4,0)
 ;;=4^H40.053
 ;;^UTILITY(U,$J,358.3,39572,2)
 ;;=^5005742
 ;;^UTILITY(U,$J,358.3,39573,0)
 ;;=H40.052^^153^1926^53
 ;;^UTILITY(U,$J,358.3,39573,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39573,1,3,0)
 ;;=3^Ocular HTN,Left Eye
 ;;^UTILITY(U,$J,358.3,39573,1,4,0)
 ;;=4^H40.052
 ;;^UTILITY(U,$J,358.3,39573,2)
 ;;=^5005741
 ;;^UTILITY(U,$J,358.3,39574,0)
 ;;=H40.051^^153^1926^54
 ;;^UTILITY(U,$J,358.3,39574,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39574,1,3,0)
 ;;=3^Ocular HTN,Right Eye
 ;;^UTILITY(U,$J,358.3,39574,1,4,0)
 ;;=4^H40.051
 ;;^UTILITY(U,$J,358.3,39574,2)
 ;;=^5005740
 ;;^UTILITY(U,$J,358.3,39575,0)
 ;;=H11.152^^153^1926^55
